{
  "id": [
    "32544799"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32544799"
  ],
  "pmcid": [
    "PMC7269953"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7269953"
      ]
    }
  ],
  "doi": [
    "10.1016/j.ejca.2020.05.026"
  ],
  "title": [
    "Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019."
  ],
  "authorString": [
    "Di Cosimo S, Malfettone A, Pérez-García JM, Llombart-Cussac A, Miceli R, Curigliano G, Cortés J."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Di Cosimo S"
          ],
          "firstName": [
            "Serena"
          ],
          "lastName": [
            "Di Cosimo"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Malfettone A"
          ],
          "firstName": [
            "Andrea"
          ],
          "lastName": [
            "Malfettone"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA and Barcelona, Spain."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Pérez-García JM"
          ],
          "firstName": [
            "José M"
          ],
          "lastName": [
            "Pérez-García"
          ],
          "initials": [
            "JM"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA and Barcelona, Spain; IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Llombart-Cussac A"
          ],
          "firstName": [
            "Antonio"
          ],
          "lastName": [
            "Llombart-Cussac"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA and Barcelona, Spain; Hospital Arnau de Vilanova, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Miceli R"
          ],
          "firstName": [
            "Rosalba"
          ],
          "lastName": [
            "Miceli"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Curigliano G"
          ],
          "firstName": [
            "Giuseppe"
          ],
          "lastName": [
            "Curigliano"
          ],
          "initials": [
            "G"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Istituto Europeo di Oncologia, IRCCS, Milano, Italy; University of Milano, School of Medicine, Milano, Italy."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Cortés J"
          ],
          "firstName": [
            "Javier"
          ],
          "lastName": [
            "Cortés"
          ],
          "initials": [
            "J"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA and Barcelona, Spain; IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain; Vall D´Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: jacortes@vhio.net."
              ]
            }
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data",
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "135"
      ],
      "journalIssueId": [
        "2980767"
      ],
      "dateOfPublication": [
        "2020 Aug"
      ],
      "monthOfPublication": [
        "8"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-08-01"
      ],
      "journal": [
        {
          "title": [
            "European journal of cancer (Oxford, England : 1990)"
          ],
          "ISOAbbreviation": [
            "Eur. J. Cancer"
          ],
          "medlineAbbreviation": [
            "Eur J Cancer"
          ],
          "NLMid": [
            "9005373"
          ],
          "ISSN": [
            "0959-8049"
          ],
          "ESSN": [
            "1879-0852"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "62-65"
  ],
  "abstractText": [
    "While confirmed cases of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease's damage. Although no proven effective therapies for treating patients with COVID-19 or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome coronavirus 2 and its interplay with hosts provides a significant number of potential drug targets and the potential to repurpose drugs already tested in other diseases. Herein, we report the biological rationale of immune-activating drugs and a brief summary of literature data on the potential therapeutic value of immune checkpoint inhibitors that have been recently tested beyond cancer treatment for their potential to restore cellular immunocompetence."
  ],
  "affiliation": [
    "Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "T-Lymphocytes"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lymphopenia"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunologic Factors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Treatment Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Apoptosis"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Randomized Controlled Trials as Topic"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Host-Pathogen Interactions"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Monoclonal, Humanized"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Programmed Cell Death 1 Receptor"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PY"
                  ],
                  "qualifierName": [
                    "pathogenicity"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "B7-H1 Antigen"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Tocilizumab",
        "Cytokine Storm",
        "Anti–pd-1",
        "Pembrolizumab",
        "Covid-19",
        "Sars-cov-2",
        "Anti–il-6r"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Immunologic Factors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "CD274 protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antibodies, Monoclonal, Humanized"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Programmed Cell Death 1 Receptor"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "PDCD1 protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "tocilizumab"
          ],
          "registryNumber": [
            "I031V2H011"
          ]
        },
        {
          "name": [
            "B7-H1 Antigen"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.ejca.2020.05.026"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7269953"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7269953?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCompletion": [
    "2020-07-28"
  ],
  "dateOfCreation": [
    "2020-06-17"
  ],
  "firstIndexDate": [
    "2020-06-17"
  ],
  "fullTextReceivedDate": [
    "2020-07-12"
  ],
  "dateOfRevision": [
    "2020-07-28"
  ],
  "electronicPublicationDate": [
    "2020-06-04"
  ],
  "firstPublicationDate": [
    "2020-06-04"
  ]
}